From: Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
Institutional background
N = 26
Percentage (%)
Government
4
15.4%
International organization
12
46.2%
Research institute
5
19.2%
Donor
3
11.5%
Vaccine manufacturer
2
7.7%